

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | melanin biosynthetic process (GO:0042438) | 9.61671384 |
| 2 | melanin metabolic process (GO:0006582) | 8.71747688 |
| 3 | secondary metabolite biosynthetic process (GO:0044550) | 8.28507262 |
| 4 | tyrosine metabolic process (GO:0006570) | 6.83280346 |
| 5 | complement activation, alternative pathway (GO:0006957) | 6.72176140 |
| 6 | response to dietary excess (GO:0002021) | 6.26429726 |
| 7 | regulation of complement activation (GO:0030449) | 5.54506499 |
| 8 | C4-dicarboxylate transport (GO:0015740) | 5.52144666 |
| 9 | regulation of protein activation cascade (GO:2000257) | 5.33549198 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.33233778 |
| 11 | regulation of cholesterol esterification (GO:0010872) | 5.32529126 |
| 12 | negative regulation of glycoprotein metabolic process (GO:1903019) | 5.30060755 |
| 13 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 5.18513924 |
| 14 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 5.16007324 |
| 15 | neurotransmitter catabolic process (GO:0042135) | 4.95678644 |
| 16 | pigment cell differentiation (GO:0050931) | 4.93930216 |
| 17 | melanocyte differentiation (GO:0030318) | 4.84897162 |
| 18 | parturition (GO:0007567) | 4.60558902 |
| 19 | prostate gland growth (GO:0060736) | 4.50658813 |
| 20 | glomerular filtration (GO:0003094) | 4.50481226 |
| 21 | cellular response to reactive nitrogen species (GO:1902170) | 4.46291670 |
| 22 | basement membrane organization (GO:0071711) | 4.43175440 |
| 23 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 4.37940519 |
| 24 | regulation of lipoprotein metabolic process (GO:0050746) | 4.37123018 |
| 25 | sexual reproduction (GO:0019953) | 4.35845418 |
| 26 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 4.35189126 |
| 27 | negative regulation of protein activation cascade (GO:2000258) | 4.27587888 |
| 28 | lung lobe morphogenesis (GO:0060463) | 4.27550760 |
| 29 | complement activation, classical pathway (GO:0006958) | 4.26686512 |
| 30 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 4.26038259 |
| 31 | macroautophagy (GO:0016236) | 4.19012104 |
| 32 | amyloid precursor protein metabolic process (GO:0042982) | 4.17237723 |
| 33 | renal filtration (GO:0097205) | 4.10859049 |
| 34 | response to phenylpropanoid (GO:0080184) | 4.07474794 |
| 35 | negative regulation of complement activation (GO:0045916) | 4.06393867 |
| 36 | basic amino acid transport (GO:0015802) | 4.04823714 |
| 37 | positive regulation of muscle hypertrophy (GO:0014742) | 3.97367011 |
| 38 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 3.97367011 |
| 39 | high-density lipoprotein particle remodeling (GO:0034375) | 3.94977551 |
| 40 | exocrine pancreas development (GO:0031017) | 3.92910271 |
| 41 | aromatic amino acid family metabolic process (GO:0009072) | 3.89926212 |
| 42 | positive regulation of developmental pigmentation (GO:0048087) | 3.89561739 |
| 43 | phospholipid efflux (GO:0033700) | 3.88977772 |
| 44 | nephron tubule formation (GO:0072079) | 3.83152122 |
| 45 | regulation of triglyceride catabolic process (GO:0010896) | 3.72566590 |
| 46 | lung vasculature development (GO:0060426) | 3.71089387 |
| 47 | chondroitin sulfate catabolic process (GO:0030207) | 3.70103156 |
| 48 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 3.63085383 |
| 49 | cellular response to nitric oxide (GO:0071732) | 3.61599211 |
| 50 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 3.60696383 |
| 51 | complement activation (GO:0006956) | 3.53363857 |
| 52 | phenol-containing compound biosynthetic process (GO:0046189) | 3.52809166 |
| 53 | reverse cholesterol transport (GO:0043691) | 3.49967950 |
| 54 | L-amino acid import (GO:0043092) | 3.45637397 |
| 55 | interleukin-6-mediated signaling pathway (GO:0070102) | 3.43107755 |
| 56 | fibroblast migration (GO:0010761) | 3.42740171 |
| 57 | negative regulation of metanephros development (GO:0072217) | 3.42252529 |
| 58 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.36202822 |
| 59 | L-phenylalanine metabolic process (GO:0006558) | 3.34503178 |
| 60 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.34503178 |
| 61 | membrane protein ectodomain proteolysis (GO:0006509) | 3.34480691 |
| 62 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 3.31131046 |
| 63 | neurotransmitter biosynthetic process (GO:0042136) | 3.20624161 |
| 64 | positive regulation of smooth muscle cell migration (GO:0014911) | 3.20213637 |
| 65 | interleukin-1-mediated signaling pathway (GO:0070498) | 3.16350168 |
| 66 | amyloid precursor protein catabolic process (GO:0042987) | 3.14060349 |
| 67 | positive regulation of glycolytic process (GO:0045821) | 3.13498325 |
| 68 | positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568) | 3.12172141 |
| 69 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.11924257 |
| 70 | L-phenylalanine catabolic process (GO:0006559) | 3.11924257 |
| 71 | neuroepithelial cell differentiation (GO:0060563) | 3.11247206 |
| 72 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 3.08979447 |
| 73 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.08463640 |
| 74 | cytolysis (GO:0019835) | 3.02792697 |
| 75 | cholesterol efflux (GO:0033344) | 3.00829583 |
| 76 | regulation of humoral immune response (GO:0002920) | 3.00253959 |
| 77 | GDP-mannose metabolic process (GO:0019673) | 2.95494063 |
| 78 | regulation of cardiac muscle hypertrophy (GO:0010611) | 2.94850457 |
| 79 | aromatic amino acid family catabolic process (GO:0009074) | 2.93880412 |
| 80 | branching involved in prostate gland morphogenesis (GO:0060442) | 2.93344861 |
| 81 | forebrain morphogenesis (GO:0048853) | 2.92962317 |
| 82 | endosome to melanosome transport (GO:0035646) | 2.91587911 |
| 83 | endosome to pigment granule transport (GO:0043485) | 2.91587911 |
| 84 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.91545183 |
| 85 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.91545183 |
| 86 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 2.91200915 |
| 87 | peptidyl-proline hydroxylation (GO:0019511) | 2.89718950 |
| 88 | glomerular basement membrane development (GO:0032836) | 2.89018253 |
| 89 | protein activation cascade (GO:0072376) | 2.88660148 |
| 90 | regulation of muscle hypertrophy (GO:0014743) | 2.88263938 |
| 91 | positive regulation of hormone metabolic process (GO:0032352) | 2.87063384 |
| 92 | lung secretory cell differentiation (GO:0061140) | 2.86910393 |
| 93 | negative regulation of macroautophagy (GO:0016242) | 2.86742683 |
| 94 | gland morphogenesis (GO:0022612) | 2.86248530 |
| 95 | negative regulation of humoral immune response (GO:0002921) | 2.85471742 |
| 96 | growth hormone receptor signaling pathway (GO:0060396) | 2.82857280 |
| 97 | indole-containing compound catabolic process (GO:0042436) | 2.77841440 |
| 98 | indolalkylamine catabolic process (GO:0046218) | 2.77841440 |
| 99 | tryptophan catabolic process (GO:0006569) | 2.77841440 |
| 100 | morphogenesis of an epithelial fold (GO:0060571) | 2.77136779 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 6.05918877 |
| 2 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.36409881 |
| 3 | GATA1_22025678_ChIP-Seq_K562_Human | 2.89496414 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.85772417 |
| 5 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.83454308 |
| 6 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.48552929 |
| 7 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.34546905 |
| 8 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.32871733 |
| 9 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.32656021 |
| 10 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.28435721 |
| 11 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.02112057 |
| 12 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.00164212 |
| 13 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.97711900 |
| 14 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.95308763 |
| 15 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.91913642 |
| 16 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.79672962 |
| 17 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.73540826 |
| 18 | VDR_22108803_ChIP-Seq_LS180_Human | 1.72244402 |
| 19 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.71493418 |
| 20 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.58379468 |
| 21 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.58330168 |
| 22 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.55699999 |
| 23 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.54676026 |
| 24 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.53951569 |
| 25 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.52895239 |
| 26 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.38680678 |
| 27 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.37484100 |
| 28 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.37164456 |
| 29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.32855801 |
| 30 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.31989874 |
| 31 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.28423254 |
| 32 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.24305693 |
| 33 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.24205318 |
| 34 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.23376810 |
| 35 | MITF_21258399_ChIP-Seq_MELANOMA_Human | 1.22129276 |
| 36 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.20869467 |
| 37 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.20865119 |
| 38 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.20806437 |
| 39 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20328720 |
| 40 | RXR_22108803_ChIP-Seq_LS180_Human | 1.18233865 |
| 41 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.15764403 |
| 42 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.14077547 |
| 43 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.12546298 |
| 44 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.08175165 |
| 45 | P300_19829295_ChIP-Seq_ESCs_Human | 1.07906061 |
| 46 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.07524086 |
| 47 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.07304715 |
| 48 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.07304715 |
| 49 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06746828 |
| 50 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.06689812 |
| 51 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.06613373 |
| 52 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.06507896 |
| 53 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.05234561 |
| 54 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.05122706 |
| 55 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.03546966 |
| 56 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.03078707 |
| 57 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.01883252 |
| 58 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.01186174 |
| 59 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.00596745 |
| 60 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.99938669 |
| 61 | AR_25329375_ChIP-Seq_VCAP_Human | 0.99628543 |
| 62 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.99104234 |
| 63 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.98392135 |
| 64 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.97821686 |
| 65 | TCF4_23295773_ChIP-Seq_U87_Human | 0.97352360 |
| 66 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.96984562 |
| 67 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.96870315 |
| 68 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.96675136 |
| 69 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.95665990 |
| 70 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.95288835 |
| 71 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.95148263 |
| 72 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.94072351 |
| 73 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.94072351 |
| 74 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93241283 |
| 75 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.92749719 |
| 76 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.92271080 |
| 77 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.92081474 |
| 78 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.91964555 |
| 79 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.91539255 |
| 80 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.91288943 |
| 81 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.90967522 |
| 82 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.90707769 |
| 83 | TP53_16413492_ChIP-PET_HCT116_Human | 0.89428794 |
| 84 | JUN_21703547_ChIP-Seq_K562_Human | 0.89303221 |
| 85 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.89038217 |
| 86 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.88757332 |
| 87 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.88378634 |
| 88 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.88091809 |
| 89 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.87438647 |
| 90 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.87359732 |
| 91 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.86597253 |
| 92 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.85533529 |
| 93 | STAT3_23295773_ChIP-Seq_U87_Human | 0.84816609 |
| 94 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.82781811 |
| 95 | ERA_21632823_ChIP-Seq_H3396_Human | 0.82592655 |
| 96 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.81788673 |
| 97 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.81511362 |
| 98 | CJUN_26792858_Chip-Seq_BT549_Human | 0.81225955 |
| 99 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.80665003 |
| 100 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.80664650 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005171_absent_coat_pigmentation | 8.14863025 |
| 2 | MP0003136_yellow_coat_color | 7.76298741 |
| 3 | MP0000372_irregular_coat_pigmentation | 6.55886982 |
| 4 | MP0005408_hypopigmentation | 5.38856290 |
| 5 | MP0005257_abnormal_intraocular_pressure | 5.05654570 |
| 6 | MP0004381_abnormal_hair_follicle | 3.53478466 |
| 7 | MP0009840_abnormal_foam_cell | 3.25928393 |
| 8 | MP0005075_abnormal_melanosome_morpholog | 3.12858243 |
| 9 | MP0002254_reproductive_system_inflammat | 3.11224556 |
| 10 | MP0000015_abnormal_ear_pigmentation | 3.06792451 |
| 11 | MP0005409_darkened_coat_color | 2.83451289 |
| 12 | MP0002877_abnormal_melanocyte_morpholog | 2.80524747 |
| 13 | MP0000371_diluted_coat_color | 2.56917116 |
| 14 | MP0002095_abnormal_skin_pigmentation | 2.51355659 |
| 15 | MP0008438_abnormal_cutaneous_collagen | 2.17873793 |
| 16 | MP0002089_abnormal_postnatal_growth/wei | 2.10297853 |
| 17 | MP0010386_abnormal_urinary_bladder | 1.97292826 |
| 18 | MP0004272_abnormal_basement_membrane | 1.84174919 |
| 19 | MP0005058_abnormal_lysosome_morphology | 1.74585757 |
| 20 | MP0002075_abnormal_coat/hair_pigmentati | 1.74430271 |
| 21 | MP0008004_abnormal_stomach_pH | 1.72250333 |
| 22 | MP0005174_abnormal_tail_pigmentation | 1.67823648 |
| 23 | MP0002938_white_spotting | 1.43146564 |
| 24 | MP0001502_abnormal_circadian_rhythm | 1.42831221 |
| 25 | MP0001186_pigmentation_phenotype | 1.31268408 |
| 26 | MP0006054_spinal_hemorrhage | 1.29847297 |
| 27 | MP0003172_abnormal_lysosome_physiology | 1.29133664 |
| 28 | MP0000467_abnormal_esophagus_morphology | 1.19947134 |
| 29 | MP0001324_abnormal_eye_pigmentation | 1.11704803 |
| 30 | MP0008872_abnormal_physiological_respon | 1.06984658 |
| 31 | MP0000604_amyloidosis | 1.06583466 |
| 32 | MP0001881_abnormal_mammary_gland | 1.06421233 |
| 33 | MP0002090_abnormal_vision | 1.00625115 |
| 34 | MP0010329_abnormal_lipoprotein_level | 0.99521401 |
| 35 | MP0004264_abnormal_extraembryonic_tissu | 0.98993328 |
| 36 | MP0001542_abnormal_bone_strength | 0.97441359 |
| 37 | MP0000920_abnormal_myelination | 0.95060132 |
| 38 | MP0000383_abnormal_hair_follicle | 0.94903221 |
| 39 | MP0001661_extended_life_span | 0.90991765 |
| 40 | MP0003879_abnormal_hair_cell | 0.85504139 |
| 41 | MP0003638_abnormal_response/metabolism_ | 0.84881682 |
| 42 | MP0003011_delayed_dark_adaptation | 0.84695827 |
| 43 | MP0006276_abnormal_autonomic_nervous | 0.81685252 |
| 44 | MP0002177_abnormal_outer_ear | 0.81285009 |
| 45 | MP0005248_abnormal_Harderian_gland | 0.75091637 |
| 46 | MP0005389_reproductive_system_phenotype | 0.71498722 |
| 47 | MP0002638_abnormal_pupillary_reflex | 0.71419114 |
| 48 | MP0005253_abnormal_eye_physiology | 0.71133181 |
| 49 | MP0005595_abnormal_vascular_smooth | 0.70014638 |
| 50 | MP0002160_abnormal_reproductive_system | 0.66506617 |
| 51 | MP0002060_abnormal_skin_morphology | 0.66322536 |
| 52 | MP0001849_ear_inflammation | 0.64921430 |
| 53 | MP0002876_abnormal_thyroid_physiology | 0.64694181 |
| 54 | MP0008961_abnormal_basal_metabolism | 0.61401653 |
| 55 | MP0000639_abnormal_adrenal_gland | 0.61312450 |
| 56 | MP0005646_abnormal_pituitary_gland | 0.60896931 |
| 57 | MP0004147_increased_porphyrin_level | 0.60451737 |
| 58 | MP0009379_abnormal_foot_pigmentation | 0.59664493 |
| 59 | MP0009053_abnormal_anal_canal | 0.58560614 |
| 60 | MP0005167_abnormal_blood-brain_barrier | 0.58393498 |
| 61 | MP0003724_increased_susceptibility_to | 0.55937269 |
| 62 | MP0010678_abnormal_skin_adnexa | 0.55077085 |
| 63 | MP0005503_abnormal_tendon_morphology | 0.54729167 |
| 64 | MP0003938_abnormal_ear_development | 0.53786079 |
| 65 | MP0002108_abnormal_muscle_morphology | 0.52520186 |
| 66 | MP0009384_cardiac_valve_regurgitation | 0.51638050 |
| 67 | MP0003633_abnormal_nervous_system | 0.51636177 |
| 68 | MP0002933_joint_inflammation | 0.50132543 |
| 69 | MP0005379_endocrine/exocrine_gland_phen | 0.49838898 |
| 70 | MP0003634_abnormal_glial_cell | 0.49283646 |
| 71 | MP0005551_abnormal_eye_electrophysiolog | 0.48595601 |
| 72 | MP0002970_abnormal_white_adipose | 0.48393285 |
| 73 | MP0002098_abnormal_vibrissa_morphology | 0.47480989 |
| 74 | MP0000579_abnormal_nail_morphology | 0.47040980 |
| 75 | MP0001299_abnormal_eye_distance/ | 0.46645243 |
| 76 | MP0003632_abnormal_nervous_system | 0.46328410 |
| 77 | MP0001873_stomach_inflammation | 0.46260987 |
| 78 | MP0001348_abnormal_lacrimal_gland | 0.46038581 |
| 79 | MP0001919_abnormal_reproductive_system | 0.45030381 |
| 80 | MP0000343_altered_response_to | 0.41959659 |
| 81 | MP0001963_abnormal_hearing_physiology | 0.39998854 |
| 82 | MP0002229_neurodegeneration | 0.39713086 |
| 83 | MP0000427_abnormal_hair_cycle | 0.37942280 |
| 84 | MP0009643_abnormal_urine_homeostasis | 0.37536426 |
| 85 | MP0001984_abnormal_olfaction | 0.37062239 |
| 86 | MP0003631_nervous_system_phenotype | 0.36935962 |
| 87 | MP0002557_abnormal_social/conspecific_i | 0.34451849 |
| 88 | MP0000767_abnormal_smooth_muscle | 0.33877567 |
| 89 | MP0001529_abnormal_vocalization | 0.33360939 |
| 90 | MP0000026_abnormal_inner_ear | 0.32802200 |
| 91 | MP0002751_abnormal_autonomic_nervous | 0.32157874 |
| 92 | MP0002735_abnormal_chemical_nociception | 0.32070425 |
| 93 | MP0000230_abnormal_systemic_arterial | 0.31709961 |
| 94 | MP0000569_abnormal_digit_pigmentation | 0.31623322 |
| 95 | MP0000358_abnormal_cell_content/ | 0.31524704 |
| 96 | MP0005164_abnormal_response_to | 0.31521348 |
| 97 | MP0005197_abnormal_uvea_morphology | 0.31367524 |
| 98 | MP0002184_abnormal_innervation | 0.31330094 |
| 99 | MP0002998_abnormal_bone_remodeling | 0.31123219 |
| 100 | MP0005670_abnormal_white_adipose | 0.30596203 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the fovea (HP:0000493) | 8.44678403 |
| 2 | Aplasia/Hypoplasia of the macula (HP:0008059) | 7.78946270 |
| 3 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 7.31984616 |
| 4 | Blue irides (HP:0000635) | 7.11398116 |
| 5 | White forelock (HP:0002211) | 5.83516110 |
| 6 | Ocular albinism (HP:0001107) | 5.41139785 |
| 7 | Patchy hypopigmentation of hair (HP:0011365) | 5.29845609 |
| 8 | Iris hypopigmentation (HP:0007730) | 4.65126152 |
| 9 | J-shaped sella turcica (HP:0002680) | 4.59468616 |
| 10 | Hypopigmentation of the fundus (HP:0007894) | 4.43105404 |
| 11 | Hypoplasia of the iris (HP:0007676) | 4.04801789 |
| 12 | Generalized hypopigmentation of hair (HP:0011358) | 3.85135769 |
| 13 | Generalized hypopigmentation (HP:0007513) | 3.77932448 |
| 14 | Paraparesis (HP:0002385) | 3.72078469 |
| 15 | Retinal atrophy (HP:0001105) | 3.49543459 |
| 16 | Anterior segment dysgenesis (HP:0007700) | 3.46342333 |
| 17 | Abnormality of glycolipid metabolism (HP:0010969) | 3.45279795 |
| 18 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.45279795 |
| 19 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.45279795 |
| 20 | Neurofibrillary tangles (HP:0002185) | 3.40214249 |
| 21 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.38136337 |
| 22 | Loss of speech (HP:0002371) | 3.34149395 |
| 23 | Increased cerebral lipofuscin (HP:0011813) | 3.26705906 |
| 24 | Spastic paraparesis (HP:0002313) | 3.07892652 |
| 25 | Congenital sensorineural hearing impairment (HP:0008527) | 2.97138577 |
| 26 | Deformed sella turcica (HP:0002681) | 2.87346040 |
| 27 | Hypothermia (HP:0002045) | 2.85295873 |
| 28 | Popliteal pterygium (HP:0009756) | 2.75558307 |
| 29 | Clumsiness (HP:0002312) | 2.74424395 |
| 30 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.73126253 |
| 31 | Albinism (HP:0001022) | 2.73006565 |
| 32 | Mitral stenosis (HP:0001718) | 2.72373399 |
| 33 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.67756039 |
| 34 | Heterochromia iridis (HP:0001100) | 2.64357567 |
| 35 | Absent eyebrow (HP:0002223) | 2.60117921 |
| 36 | Dysostosis multiplex (HP:0000943) | 2.59851120 |
| 37 | Abnormal glucose tolerance (HP:0001952) | 2.56372066 |
| 38 | Systemic lupus erythematosus (HP:0002725) | 2.54800046 |
| 39 | Neurodegeneration (HP:0002180) | 2.54170058 |
| 40 | Glomerulonephritis (HP:0000099) | 2.54123532 |
| 41 | Large eyes (HP:0001090) | 2.53461137 |
| 42 | Complement deficiency (HP:0004431) | 2.52833703 |
| 43 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 2.41693973 |
| 44 | Thyroid-stimulating hormone excess (HP:0002925) | 2.35645312 |
| 45 | Esophageal neoplasm (HP:0100751) | 2.34945280 |
| 46 | Neoplasm of head and neck (HP:0012288) | 2.34945280 |
| 47 | Cerebral aneurysm (HP:0004944) | 2.33813873 |
| 48 | Mesangial abnormality (HP:0001966) | 2.31472226 |
| 49 | Abnormality of the anterior chamber (HP:0000593) | 2.30631230 |
| 50 | Trismus (HP:0000211) | 2.29777131 |
| 51 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.29345517 |
| 52 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.29345517 |
| 53 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.29345517 |
| 54 | Focal segmental glomerulosclerosis (HP:0000097) | 2.25157162 |
| 55 | Glucose intolerance (HP:0000833) | 2.23952059 |
| 56 | Neonatal short-limb short stature (HP:0008921) | 2.23608881 |
| 57 | Hand muscle atrophy (HP:0009130) | 2.21873937 |
| 58 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.15771583 |
| 59 | Mucopolysacchariduria (HP:0008155) | 2.10613055 |
| 60 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.10613055 |
| 61 | Alacrima (HP:0000522) | 2.06913722 |
| 62 | Cerebral inclusion bodies (HP:0100314) | 2.02848332 |
| 63 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 10.3231698 |
| 64 | Hypoplasia of the fovea (HP:0007750) | 10.3231698 |
| 65 | Facial cleft (HP:0002006) | 1.99965717 |
| 66 | Absent hair (HP:0002298) | 1.93716283 |
| 67 | Xanthomatosis (HP:0000991) | 1.91575415 |
| 68 | Upper limb amyotrophy (HP:0009129) | 1.90976581 |
| 69 | Distal upper limb amyotrophy (HP:0007149) | 1.90976581 |
| 70 | Premature graying of hair (HP:0002216) | 1.90559253 |
| 71 | Birth length less than 3rd percentile (HP:0003561) | 1.90034553 |
| 72 | Freckling (HP:0001480) | 1.89656051 |
| 73 | Alveolar cell carcinoma (HP:0006519) | 1.89092836 |
| 74 | Premature skin wrinkling (HP:0100678) | 1.88545276 |
| 75 | Abnormality of complement system (HP:0005339) | 1.86762109 |
| 76 | Nephritis (HP:0000123) | 1.86684337 |
| 77 | Hypoplastic labia majora (HP:0000059) | 1.81719715 |
| 78 | Global brain atrophy (HP:0002283) | 1.81190905 |
| 79 | Abnormality of the sella turcica (HP:0002679) | 1.78599856 |
| 80 | Rhabdomyosarcoma (HP:0002859) | 1.77605656 |
| 81 | Renovascular hypertension (HP:0100817) | 1.74420968 |
| 82 | Glomerulosclerosis (HP:0000096) | 1.73694579 |
| 83 | Median cleft lip (HP:0000161) | 1.73496334 |
| 84 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.72331279 |
| 85 | Gastrointestinal stroma tumor (HP:0100723) | 1.70884437 |
| 86 | Absent eyelashes (HP:0000561) | 1.70247555 |
| 87 | Decreased lacrimation (HP:0000633) | 1.66412108 |
| 88 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.65797973 |
| 89 | Prostate neoplasm (HP:0100787) | 1.65512577 |
| 90 | Occipital encephalocele (HP:0002085) | 1.64953168 |
| 91 | Vascular calcification (HP:0004934) | 1.62888048 |
| 92 | Cutaneous melanoma (HP:0012056) | 1.59452880 |
| 93 | Abnormality of vision evoked potentials (HP:0000649) | 1.57765912 |
| 94 | Hoarse voice (HP:0001609) | 1.55389328 |
| 95 | Abnormality of the nasal septum (HP:0000419) | 1.54030504 |
| 96 | Abnormality of the labia majora (HP:0012881) | 1.54009125 |
| 97 | Vertebral compression fractures (HP:0002953) | 1.53153467 |
| 98 | Chronic hepatic failure (HP:0100626) | 1.49314390 |
| 99 | Neoplasm of striated muscle (HP:0009728) | 1.49025763 |
| 100 | Nonimmune hydrops fetalis (HP:0001790) | 1.48871187 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K3 | 4.52508406 |
| 2 | MAP3K2 | 4.43538785 |
| 3 | MST1R | 4.12763344 |
| 4 | NTRK3 | 4.08515947 |
| 5 | PIK3CA | 3.97271941 |
| 6 | NLK | 3.24093021 |
| 7 | PDK2 | 3.19953089 |
| 8 | TAOK3 | 3.15366642 |
| 9 | CSNK1G1 | 2.49850136 |
| 10 | MARK3 | 2.44811789 |
| 11 | MET | 2.36122635 |
| 12 | WEE1 | 2.17199815 |
| 13 | ERBB4 | 2.09909236 |
| 14 | BMPR1B | 1.87961090 |
| 15 | MAPKAPK3 | 1.87219653 |
| 16 | PDGFRB | 1.85222228 |
| 17 | PDGFRA | 1.78034741 |
| 18 | JAK1 | 1.76479380 |
| 19 | GRK1 | 1.64881030 |
| 20 | CSNK1G3 | 1.63043815 |
| 21 | PRKD3 | 1.59508270 |
| 22 | FRK | 1.52589915 |
| 23 | KIT | 1.42691064 |
| 24 | CSNK1G2 | 1.41517055 |
| 25 | CSNK1A1L | 1.37544538 |
| 26 | ACVR1B | 1.25754913 |
| 27 | CDC42BPA | 1.16027066 |
| 28 | INSRR | 1.15973482 |
| 29 | LMTK2 | 1.09716650 |
| 30 | SGK2 | 1.06209009 |
| 31 | MELK | 1.05468375 |
| 32 | MATK | 1.04840767 |
| 33 | RPS6KA2 | 0.99627861 |
| 34 | ADRBK2 | 0.94943394 |
| 35 | DYRK1A | 0.92755652 |
| 36 | MAP2K2 | 0.91512821 |
| 37 | NEK6 | 0.87995902 |
| 38 | PKN1 | 0.85957510 |
| 39 | CAMK4 | 0.85591067 |
| 40 | SGK3 | 0.85413287 |
| 41 | ERBB2 | 0.85109321 |
| 42 | MAP4K2 | 0.80174903 |
| 43 | RET | 0.79539402 |
| 44 | SGK223 | 0.77631330 |
| 45 | SGK494 | 0.77631330 |
| 46 | NME1 | 0.77028827 |
| 47 | EPHA3 | 0.76456607 |
| 48 | SIK2 | 0.74451960 |
| 49 | FLT3 | 0.73311903 |
| 50 | SIK3 | 0.73297998 |
| 51 | MAP3K7 | 0.72905283 |
| 52 | CDK3 | 0.72573549 |
| 53 | MAP3K6 | 0.72081398 |
| 54 | NEK9 | 0.69858851 |
| 55 | GSK3A | 0.69547468 |
| 56 | AKT3 | 0.69248490 |
| 57 | TXK | 0.68354590 |
| 58 | MAPK7 | 0.64008751 |
| 59 | JAK2 | 0.60769055 |
| 60 | PKN2 | 0.60194115 |
| 61 | NTRK1 | 0.59347811 |
| 62 | ZAP70 | 0.59332046 |
| 63 | ADRBK1 | 0.58874649 |
| 64 | PRKD1 | 0.55343853 |
| 65 | AKT2 | 0.53483853 |
| 66 | PDPK1 | 0.53306818 |
| 67 | TRIM28 | 0.51669457 |
| 68 | ERN1 | 0.51619794 |
| 69 | STK39 | 0.50040604 |
| 70 | EIF2AK3 | 0.48789406 |
| 71 | PHKG1 | 0.48585295 |
| 72 | PHKG2 | 0.48585295 |
| 73 | MAP2K6 | 0.47611562 |
| 74 | FER | 0.47099131 |
| 75 | TIE1 | 0.46175010 |
| 76 | ICK | 0.45600149 |
| 77 | ABL2 | 0.45514243 |
| 78 | CASK | 0.41834057 |
| 79 | PTK2 | 0.41580686 |
| 80 | CSNK1D | 0.40647873 |
| 81 | SIK1 | 0.39455192 |
| 82 | LIMK1 | 0.38376538 |
| 83 | TGFBR1 | 0.36535386 |
| 84 | IGF1R | 0.33885351 |
| 85 | PDK1 | 0.33831368 |
| 86 | MARK2 | 0.33237652 |
| 87 | LATS1 | 0.31554026 |
| 88 | PRKCG | 0.31549547 |
| 89 | CSNK1A1 | 0.31117115 |
| 90 | WNK4 | 0.29965706 |
| 91 | DAPK2 | 0.29956081 |
| 92 | CHUK | 0.29614372 |
| 93 | MAP3K5 | 0.29461179 |
| 94 | PRKCE | 0.29432688 |
| 95 | WNK3 | 0.28476653 |
| 96 | CHEK2 | 0.26641057 |
| 97 | MAP2K1 | 0.25339083 |
| 98 | STK38L | 0.24494616 |
| 99 | MAPK13 | 0.22179019 |
| 100 | MAPK11 | 0.22165298 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.78625341 |
| 2 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 3.53147582 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.28888331 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.79043172 |
| 5 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.72606278 |
| 6 | Lysosome_Homo sapiens_hsa04142 | 2.70652876 |
| 7 | Histidine metabolism_Homo sapiens_hsa00340 | 2.59970815 |
| 8 | Prion diseases_Homo sapiens_hsa05020 | 2.37360406 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.32624032 |
| 10 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 2.30639296 |
| 11 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.07858974 |
| 12 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.89744320 |
| 13 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.88800210 |
| 14 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.86465166 |
| 15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.77032122 |
| 16 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.76562445 |
| 17 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.70583563 |
| 18 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.70305363 |
| 19 | ABC transporters_Homo sapiens_hsa02010 | 1.56894736 |
| 20 | Circadian rhythm_Homo sapiens_hsa04710 | 1.51645586 |
| 21 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.50567724 |
| 22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.44244228 |
| 23 | Melanoma_Homo sapiens_hsa05218 | 1.41408890 |
| 24 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.39166060 |
| 25 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.36013975 |
| 26 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.34192648 |
| 27 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.33486569 |
| 28 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.32517424 |
| 29 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.32173024 |
| 30 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.31379536 |
| 31 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.28877777 |
| 32 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.26671675 |
| 33 | Prostate cancer_Homo sapiens_hsa05215 | 1.26457186 |
| 34 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.18016449 |
| 35 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.16456206 |
| 36 | Amoebiasis_Homo sapiens_hsa05146 | 1.15193754 |
| 37 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.14960681 |
| 38 | Retinol metabolism_Homo sapiens_hsa00830 | 1.10043508 |
| 39 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.09359934 |
| 40 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.07260487 |
| 41 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.05234018 |
| 42 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.00651669 |
| 43 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.97238094 |
| 44 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.96041768 |
| 45 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.95553457 |
| 46 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.95532166 |
| 47 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.93818213 |
| 48 | Peroxisome_Homo sapiens_hsa04146 | 0.90333141 |
| 49 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.85505118 |
| 50 | Glioma_Homo sapiens_hsa05214 | 0.84383353 |
| 51 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.83595053 |
| 52 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.82483273 |
| 53 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.82344240 |
| 54 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.80544906 |
| 55 | Insulin resistance_Homo sapiens_hsa04931 | 0.80361676 |
| 56 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.80281403 |
| 57 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.76718111 |
| 58 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.75572689 |
| 59 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.75564760 |
| 60 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.74885218 |
| 61 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.74670668 |
| 62 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.72487979 |
| 63 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.71399513 |
| 64 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.71252931 |
| 65 | Sulfur relay system_Homo sapiens_hsa04122 | 0.70464399 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.68197859 |
| 67 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64448626 |
| 68 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.62928182 |
| 69 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.58840967 |
| 70 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.56335589 |
| 71 | Protein export_Homo sapiens_hsa03060 | 0.55999832 |
| 72 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.52026615 |
| 73 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.51213412 |
| 74 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.50245039 |
| 75 | Melanogenesis_Homo sapiens_hsa04916 | 0.46199696 |
| 76 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.45717799 |
| 77 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.45299445 |
| 78 | Mineral absorption_Homo sapiens_hsa04978 | 0.45163470 |
| 79 | Cocaine addiction_Homo sapiens_hsa05030 | 0.44939804 |
| 80 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.42953735 |
| 81 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.42611711 |
| 82 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.42483962 |
| 83 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41113211 |
| 84 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.40770297 |
| 85 | Focal adhesion_Homo sapiens_hsa04510 | 0.39988099 |
| 86 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.38098729 |
| 87 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.37723452 |
| 88 | Lysine degradation_Homo sapiens_hsa00310 | 0.36414866 |
| 89 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.35079108 |
| 90 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.33592562 |
| 91 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33491467 |
| 92 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.33435691 |
| 93 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.32491261 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.30813219 |
| 95 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.30517298 |
| 96 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.29672082 |
| 97 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.28986727 |
| 98 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.27551774 |
| 99 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.26048804 |
| 100 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.25395881 |

